| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 05/27/2004 | WO2004037311A3 Device and methods for sequential, regional delivery of multiple cytotoxic agents |
| 05/27/2004 | WO2004031143A3 Novel combination of a factor xa inhibitor and clopidogrel |
| 05/27/2004 | WO2004028521A3 Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders |
| 05/27/2004 | WO2004010937A3 Method of treating cancer |
| 05/27/2004 | WO2004009762A3 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 05/27/2004 | WO2004008147A3 Diagnosis and prevention of cancer cell invasion |
| 05/27/2004 | WO2004006842A3 Combinations of drugs for the treatment of neoplasms |
| 05/27/2004 | WO2004004725A3 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
| 05/27/2004 | WO2004004702A3 Method to inhibit ischemia and reperfusion injury |
| 05/27/2004 | WO2004001655A8 Methods of treating and preventing colitis involving il-13 and nk-t cells |
| 05/27/2004 | WO2003099992A3 Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins |
| 05/27/2004 | WO2003088985A8 Use of compositions containing petasites for treating diseases |
| 05/27/2004 | WO2003082926A9 Antimicrobial polymer conjugates |
| 05/27/2004 | WO2003081258A3 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs) |
| 05/27/2004 | WO2003075833A3 Screening method for orthopoxvirus antivirals |
| 05/27/2004 | WO2003064448A3 Degp protease: cleavage site identification and proteolysis of a natural target in e. coli |
| 05/27/2004 | WO2003045229A3 Methods and compositions for treating cancer |
| 05/27/2004 | WO2003035050A3 Use of tyrosine kinase inhibitors for promoting hair growth |
| 05/27/2004 | WO2003006002A8 Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases |
| 05/27/2004 | WO2003004604A3 Phage displayed pdz domain ligands |
| 05/27/2004 | WO2003002109A3 Use of tyrosine kinase inhibitors for treating autoimmune diseases |
| 05/27/2004 | WO2003000295A3 Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors |
| 05/27/2004 | WO2002085304A3 Proliposomal drug delivery system |
| 05/27/2004 | WO2002072088A3 Modulators of kcnq potassium channels and use thereof in treating migraine and mechanistically related diseases |
| 05/27/2004 | WO2002062362A8 Antiviral and antibacterial composition |
| 05/27/2004 | WO2002060480A9 Methods for treating or preventing skin disorders using cd2-binding agents |
| 05/27/2004 | WO2002055721B1 Modular transfection systems based on nucleoprotein filaments |
| 05/27/2004 | WO1999046281A8 Novel polypeptides and nucleic acids encoding the same |
| 05/27/2004 | US20040102758 Medical devices, drug coatings and methods for maintaining the drug coatings thereon |
| 05/27/2004 | US20040102524 Method of treatment |
| 05/27/2004 | US20040102512 Statins reduce or repress T-lymphocyte activation mediated by MHC class II or CD40; new target is alternative to cytokine inhibitors |
| 05/27/2004 | US20040102506 Pyrazole compositions useful as inhibitors of ERK |
| 05/27/2004 | US20040102504 Compositions based on aminoacids, suitable for the treatment of heart failure |
| 05/27/2004 | US20040102497 Novel inhibitors of IMPDH enzyme |
| 05/27/2004 | US20040102495 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 05/27/2004 | US20040102475 Methods for treatment of erectile dysfunction |
| 05/27/2004 | US20040102474 Dietetics; antidiabetic agents; eating disorders |
| 05/27/2004 | US20040102467 Antiinflammatory agents; central nervous system disorders; antiproliferative agents |
| 05/27/2004 | US20040102459 Central nervous system disorders; Parkinson's disease; antidepressants |
| 05/27/2004 | US20040102458 Antiproliferative agents; antitumor agents; binding to chaperone protein |
| 05/27/2004 | US20040102448 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| 05/27/2004 | US20040102445 Synergistic mixture; hypotensive agents for eyes |
| 05/27/2004 | US20040102440 Method of promoting smoking cessation |
| 05/27/2004 | US20040102431 Protease inhibitors |
| 05/27/2004 | US20040102424 Hypotensive agents; cardiovascular diosrders |
| 05/27/2004 | US20040102423 Spironolactone and angiotensin II antagonist combination therapy for treatment of congestive heart failure |
| 05/27/2004 | US20040102421 Tocopherol and tocotrienol anti-inflammatory medicaments |
| 05/27/2004 | US20040102407 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer |
| 05/27/2004 | US20040102383 Growth inhibition and eradication of solid tumors using neuroendocrine resetting therapy and photodynamic therapy |
| 05/27/2004 | US20040102381 Methods of altering the binding affinity of a peptide to its receptor |
| 05/27/2004 | US20040102379 Fibroblast growth factor homologous factors (FHFs) and methods of use |
| 05/27/2004 | US20040102374 Methods for controlling the lysis of coagulated blood with apolipoprotein e4 theno type |
| 05/27/2004 | US20040102361 Pharmaceutical composition for the treatment of pulmonary arterial hypertension |
| 05/27/2004 | US20040102360 Combination therapy |
| 05/27/2004 | US20040101915 Diagnosis and treatment of chemoresistant tumors |
| 05/27/2004 | US20040101911 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 05/27/2004 | US20040101882 Secreted proteins |
| 05/27/2004 | US20040101865 Comprises nucleotide sequences coding polypeptides associated with biosynthesis and metabolism of acetyl-CoA for preparing food, feed, cosmetics and pharmaceutical agents |
| 05/27/2004 | US20040101833 Human TREK2, a stretch- and arachidonic acid-sensitive K+ channel activated by inhalational anesthetics and riluzole |
| 05/27/2004 | US20040101565 Mehtod to obtain microparticles containing a h+ k+ atp-ase inhibitor |
| 05/27/2004 | US20040101554 Fatty acid in soft gelatin capsule; plant and animal extracts; controlling taste |
| 05/27/2004 | US20040101538 Synergistic mixture of terbinafine with diclofenac or indomethacin; fungicide |
| 05/27/2004 | US20040101529 Regulation of human serine-threonine protein kinase |
| 05/27/2004 | DE10147638B4 Leukozyten-Inaktivierungs-Modul (LIM) Leukocyte inactivation module (LIM) |
| 05/27/2004 | CA2509252A1 Synergistic combinations with analgesic properties comprising n-acylated 4-hydroxyphenylamine derivatives |
| 05/27/2004 | CA2505557A1 Mucin synthesis inhibitors |
| 05/27/2004 | CA2505523A1 Compositions containing peptide copper complexes and metalloproteinase inhibitors, and methods related thereto |
| 05/27/2004 | CA2505355A1 Methods for predicting whether subjects with mild cognitive impairment (mci) will develop alzheimer's disease |
| 05/27/2004 | CA2505131A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases |
| 05/27/2004 | CA2504916A1 Cholesterol absorptions inhibitors for the treatment of autoimmune disorders |
| 05/27/2004 | CA2504878A1 Cholesterol absorption inhibitors for the treatment of demyelination |
| 05/27/2004 | CA2504666A1 Combination product of inhibitor of the src family of non-receptor tyrosine kinases and gemcitabine |
| 05/27/2004 | CA2504611A1 Combination therapy for the treatment of acute leukemia and myelodysplastic syndrome |
| 05/27/2004 | CA2504604A1 Treatment for hemorrhagic shock |
| 05/27/2004 | CA2502363A1 Irrigation solution and method for inhibition of tumor cell adhesion, pain and inflammation |
| 05/27/2004 | CA2492103A1 Flavin n-oxides: new anti-cancer agents and pathogen eradication agents |
| 05/27/2004 | CA2412856A1 Pharmaceutical composition for the treatment of pulmonary arterial hypertension |
| 05/26/2004 | EP1422225A1 Benzoisoselenazole derivatives with anti-inflammation, antivirus and anti-thrombosis activity and their use |
| 05/26/2004 | EP1421954A1 Materials sustainedly releasing drug in vivo |
| 05/26/2004 | EP1421953A1 Medicinal compositions containing angiotensin ii receptor antagonist |
| 05/26/2004 | EP1421946A1 A pharmaceutical being used for treating hiv infection, the composition and uses thereof |
| 05/26/2004 | EP1421858A1 Use of medium chain triglycerides (MCT) for the nutritional optimisation of the lipid composition of a dietetic product for diabetics |
| 05/26/2004 | EP1421391A2 Sodium channel regulators and modulators |
| 05/26/2004 | EP1421384A2 Hprp4s as modifiers of the p53 pathway and methods of use |
| 05/26/2004 | EP1421377A2 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 05/26/2004 | EP1421222A2 Cell culture system for synthesis of infectious hepatitis c virus |
| 05/26/2004 | EP1421198A2 Cell-based high-throughput screening methods |
| 05/26/2004 | EP1421174A2 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 05/26/2004 | EP1421170A2 Therapeutic delivery compositions and methods of use thereof |
| 05/26/2004 | EP1421118A1 A method for the treatment or prevention of bone erosion |
| 05/26/2004 | EP1421113A1 Methods of screening based on the egf receptor crystal structure |
| 05/26/2004 | EP1421111A2 Proteins associated with cell growth differentiation, and death |
| 05/26/2004 | EP1421101A2 P-glycoproteins and uses thereof |
| 05/26/2004 | EP1421092A1 Neutral glycosphingolipids and glycosyl-sphingosines and methods for isolating the same |
| 05/26/2004 | EP1421084A1 Polycyclic guanine phosphodiesterase v inhibitors |
| 05/26/2004 | EP1421083A1 Novel imidazopyridine compounds with therapeutic effect |
| 05/26/2004 | EP1421075A1 Piperidine derivatives useful as ccr5 antagonists |
| 05/26/2004 | EP1420851A1 Use of a blood-flow decrease preventing agent in conjunction with insufflating gas |
| 05/26/2004 | EP1420826A2 Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof |
| 05/26/2004 | EP1420816A2 Uses of mammalian cytokine; related reagents |